SUMMARY OF STOCK OPTION ACTIVITY (Details) - USD ($) |
3 Months Ended | 12 Months Ended |
---|---|---|
Mar. 31, 2023 |
Dec. 31, 2022 |
|
Share-Based Payment Arrangement [Abstract] | ||
Option outstanding, beginning balance | 177,815 | |
Weighted average exercise price outstanding, balance | $ 12.57 | |
Weighted average remaining contractual term outstanding, ending | 8 years 6 months 21 days | 8 years 9 months 18 days |
Aggregate Intrinsic Value, Beginning balance | ||
Options, granted | ||
Weighted average exercise price, granted | ||
Option outstanding, ending balance | 177,815 | 177,815 |
Weighted average exercise price outstanding, ending balance | $ 12.57 | $ 12.57 |
Aggregate intrinsic value, ending balance |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|